FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Paul McCarron

Research Profile

Chemicals & Drugs

Procedures

Concepts & Ideas

Objects

Nanoparticles

Physiology

Skin Absorption

Anatomy

Skin

Phenomena

Diffusion

Co-author Network

Publications

TOP 3
Desmond I J Morrow; Paul A McCarron; A David Woolfson; Petras Juzenas; Asta Juzeniene; Vladimir Iani; Johan Moan; Ryan F Donnelly
Novel patch-based systems for the localised delivery of ALA-esters.
Desmond I J Morrow; Paul A McCarron; A David Woolfson; Petras Juzenas; Asta Juzeniene; Vladimir Iani; Johan Moan; Ryan F Donnelly
Hexyl aminolaevulinate is a more effective topical photosensitiser precursor than methyl aminolaevulinate and 5-aminolaevulinic acids when applied in equimolar doses.
Desmond I J Morrow; Paul A McCarron; A David Woolfson; Petras Juzenas; Asta Juzeniene; Vladimir Iani; Johan Moan; Ryan F Donnelly
Influence of penetration enhancers on topical delivery of 5-aminolevulinic acid from bioadhesive patches.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Paul McCarron (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Desmond I J Morrow; Paul A McCarron; A David Woolfson; Petras Juzenas; Asta Juzeniene; Vladimir Iani; Johan Moan; Ryan F Donnelly
Novel patch-based systems for the localised delivery of ALA-esters.
Journal of photochemistry and photobiology. B, Biology 2010;101(1):59-69.
2010: Desmond I J Morrow; Paul A McCarron; A David Woolfson; Petras Juzenas; Asta Juzeniene; Vladimir Iani; Johan Moan; Ryan F Donnelly
Hexyl aminolaevulinate is a more effective topical photosensitiser precursor than methyl aminolaevulinate and 5-aminolaevulinic acids when applied in equimolar doses.
Journal of pharmaceutical sciences 2010;99(8):3486-98.
2010: Desmond I J Morrow; Paul A McCarron; A David Woolfson; Petras Juzenas; Asta Juzeniene; Vladimir Iani; Johan Moan; Ryan F Donnelly
Influence of penetration enhancers on topical delivery of 5-aminolevulinic acid from bioadhesive patches.
The Journal of pharmacy and pharmacology 2010;62(6):685-95.
2010: François Fay; Derek J Quinn; Brendan F Gilmore; Paul A McCarron; Christopher J Scott
Gene delivery using dimethyldidodecylammonium bromide-coated PLGA nanoparticles.
Biomaterials 2010;31(14):4214-22.
2009: Ryan F Donnelly; Thakur Raghu Raj Singh; Michael M Tunney; Desmond I J Morrow; Paul A McCarron; Conor O'Mahony; A David Woolfson
Microneedle arrays allow lower microbial penetration than hypodermic needles in vitro.
Pharmaceutical research 2009;26(11):2513-22.
2009: Ryan F Donnelly; Desmond I J Morrow; Thakur R R Singh; Katarzyna Migalska; Paul A McCarron; Conor O'Mahony; A David Woolfson
Processing difficulties and instability of carbohydrate microneedle arrays.
Drug development and industrial pharmacy 2009;35(10):1242-54.
2009: Ryan F Donnelly; Corona M Cassidy; Ryan G Loughlin; Anthony Brown; Michael M Tunney; Mark G Jenkins; Paul A McCarron
Delivery of Methylene Blue and meso-tetra (N-methyl-4-pyridyl) porphine tetra tosylate from cross-linked poly(vinyl alcohol) hydrogels: a potential means of photodynamic therapy of infected wounds.
Journal of photochemistry and photobiology. B, Biology 2009;96(3):223-31.
2009: Rasil Al-Kassas; Ryan F Donnelly; Paul A McCarron
Aminolevulinic acid-loaded Witepsol microparticles manufactured using a spray congealing procedure: implications for topical photodynamic therapy.
The Journal of pharmacy and pharmacology 2009;61(9):1125-35.
2009: Corona M Cassidy; Michael M Tunney; Paul A McCarron; Ryan F Donnelly
Drug delivery strategies for photodynamic antimicrobial chemotherapy: from benchtop to clinical practice.
Journal of photochemistry and photobiology. B, Biology 2009;95(2):71-80.
2009: Agnieszka A Zawislak; William G McCluggage; Ryan F Donnelly; Peter Maxwell; John H Price; Stephen Dobbs; H Raymond McClelland; A David Woolfson; Paul A McCarron
Response of vulval lichen sclerosus and squamous hyperplasia to photodynamic treatment using sustained topical delivery of aminolevulinic acid from a novel bioadhesive patch system.
Photodermatology, photoimmunology & photomedicine 2009;25(2):111-3.
2009: Agnieszka A Zawislak; Ryan F Donnelly; W Glenn McCluggage; John H Price; H Raymond McClelland; A David Woolfson; Stephen Dobbs; P Maxwell; Paul A McCarron
Clinical and immunohistochemical assessment of vulval intraepithelial neoplasia following photodynamic therapy using a novel bioadhesive patch-type system loaded with 5-aminolevulinic acid.
Photodiagnosis and photodynamic therapy 2009;6(1):28-40.
2009: Ryan F Donnelly; Paul A McCarron; Rasil Al-Kassas; Asta Juzeniene; Petras Juzenas; Vladimir Iani; A David Woolfson; Johan Moan
Influence of formulation factors on PpIX production and photodynamic action of novel ALA-loaded microparticles.
Biopharmaceutics & drug disposition 2009;30(2):55-70.
2009: Ryan F Donnelly; Paul A McCarron; David Woolfson
Drug delivery systems for photodynamic therapy.
Recent patents on drug delivery & formulation 2009;3(1):1-7.
2009: Ryan F Donnelly; Desmond I J Morrow; Paul A McCarron; A David Woolfson; Anthony Morrissey; Petras Juzenas; Asta Juzeniene; Vladimir Iani; Helen O McCarthy; Johan Moan
Microneedle arrays permit enhanced intradermal delivery of a preformed photosensitizer.
Photochemistry and photobiology 2009;85(1):195-204.
2008: Paul A McCarron; Waleed M Marouf; Ryan F Donnelly; Chris Scott
Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality.
Journal of biomedical materials research. Part A 2008;87(4):873-84.
2008: Stéphane SIBANI; Paul A McCarron; A David Woolfson; Ryan F Donnelly
Photosensitiser delivery for photodynamic therapy. Part 2: systemic carrier platforms.
Expert opinion on drug delivery 2008;5(11):1241-54.
2008: Ryan F Donnelly; Desmond I J Morrow; Paul A McCarron; A David Woolfson; Anthony Morrissey; Petras Juzenas; Asta Juzeniene; Vladimir Iani; Helen O McCarthy; Johan Moan
Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy.
Journal of controlled release : official journal of the Controlled Release Society 2008;129(3):154-62.
2008: Nabla McLoone; Ryan F Donnelly; Maureen Walsh; OM Dolan; Sean McLoone; Kevin McKenna; Paul A McCarron
Aminolaevulinic acid diffusion characteristics in 'in vitro' normal human skin and actinic keratosis: implications for topical photodynamic therapy.
Photodermatology, photoimmunology & photomedicine 2008;24(4):183-90.
2008: Paul A McCarron; Waleed M Marouf; Derek J Quinn; Francois Fay; Roberta E Burden; Shane A Olwill; Christopher J Scott
Antibody targeting of camptothecin-loaded PLGA nanoparticles to tumor cells.
Bioconjugate chemistry 2008;19(8):1561-9.
2008: Ryan G Loughlin; Michael M Tunney; Ryan F Donnelly; Diarmaid J Murphy; Mark Jenkins; Paul A McCarron
Modulation of gel formation and drug-release characteristics of lidocaine-loaded poly(vinyl alcohol)-tetraborate hydrogel systems using scavenger polyol sugars.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2008;69(3):1135-46.
2008: Ryan F Donnelly; Paul A McCarron; Desmond I J Morrow; Stéphane SIBANI; A David Woolfson
Photosensitiser delivery for photodynamic therapy. Part 1: Topical carrier platforms.
Expert opinion on drug delivery 2008;5(7):757-66.
2008: R Loughlin; Brendan F Gilmore; Paul A McCarron; Michael M Tunney
Comparison of the cidal activity of tea tree oil and terpinen-4-ol against clinical bacterial skin isolates and human fibroblast cells.
Letters in applied microbiology 2008;46(4):428-33.
2008: Paul A McCarron; Ryan F Donnelly; A David Woolfson
Autoradiographic and scintillation analysis of 5-aminolevulinic acid permeation through epithelialised tissue: implications for topical photodynamic therapy of superficial gynaecological neoplasias.
Pharmaceutical research 2008;25(4):812-26.
2008: Paul A McCarron; M Hall
Incorporation of novel 1-alkylcarbonyloxymethyl prodrugs of 5-fluorouracil into poly(lactide-co-glycolide) nanoparticles.
International journal of pharmaceutics 2008;348(1-2):115-24.
2008: Ryan F Donnelly; Paul A McCarron; A David Woolfson
Derivatives of 5-aminolevulinic Acid for photodynamic therapy.
Perspectives in medicinal chemistry 2008;1():49-63.
2008: Ryan F Donnelly; Paul A McCarron; Michael M Tunney
Antifungal photodynamic therapy.
Microbiological research 2008;163(1):1-12.
2008: Christopher J Scott; Waleed M Marouf; Derek J Quinn; Richard J Buick; Selinda J Orr; Ryan F Donnelly; Paul A McCarron
Immunocolloidal targeting of the endocytotic siglec-7 receptor using peripheral attachment of siglec-7 antibodies to poly(lactide-co-glycolide) nanoparticles.
Pharmaceutical research 2008;25(1):135-46.
2007: Ryan F Donnelly; Desmond I J Morrow; Paul A McCarron; Martin J Garland; A David Woolfson
Influence of solution viscosity and injection protocol on distribution patterns of jet injectors: application to photodynamic tumour targeting.
Journal of photochemistry and photobiology. B, Biology 2007;89(2-3):98-109.
2007: Paul A McCarron; Ryan F Donnelly; Waleed Marouf; Deborah E Calvert
Anti-adherent and antifungal activities of surfactant-coated poly(ethylcyanoacrylate) nanoparticles.
International journal of pharmaceutics 2007;340(1-2):182-90.
2007: Agnieszka A Zawislak; Paul A McCarron; W Glenn McCluggage; Ryan F Donnelly; John H Price; H Raymond McClelland; A David Woolfson
Novel bioadhesive patch-type system for photodynamic vulvodynia therapy after delivery of 5-aminolevulinic acid: preliminary evaluation.
The Journal of reproductive medicine 2007;52(7):645-53.
2007: Ryan F Donnelly; Paul A McCarron; Corona M Cassidy; J Stuart Elborn; Michael M Tunney
Delivery of photosensitisers and light through mucus: investigations into the potential use of photodynamic therapy for treatment of Pseudomonas aeruginosa cystic fibrosis pulmonary infection.
Journal of controlled release : official journal of the Controlled Release Society 2007;117(2):217-26.
2007: Ryan F Donnelly; Paul A McCarron; Michael M Tunney; A David Woolfson
Potential of photodynamic therapy in treatment of fungal infections of the mouth. Design and characterisation of a mucoadhesive patch containing toluidine blue O.
Journal of photochemistry and photobiology. B, Biology 2007;86(1):59-69.
2007: Paul A McCarron; Gavin P Andrews; Desmond I J Morrow; A David Woolfson; Ryan F Donnelly
Formulation and characterization of poly(ethylene glycol)-based, 5-aminolevulinic acid-loaded solid-dosage forms intended for photodynamic and photodiagnostic methodologies in the colorectal region.
Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer 2007;26(2):135-42.
2007: Desmond I J Morrow; Martin J Garland; Paul A McCarron; A David Woolfson; Ryan F Donnelly
Innovative drug delivery strategies for topical photodynamic therapy using porphyrin precursors.
Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer 2007;26(2):105-16.
2006: Paul A McCarron; Ryan F Donnelly; Waleed Marouf
Celecoxib-loaded poly(D,L-lactide-co-glycolide) nanoparticles prepared using a novel and controllable combination of diffusion and emulsification steps as part of the salting-out procedure.
Journal of microencapsulation 2006;23(5):480-98.
2006: Brendan F Gilmore; Paul A McCarron; Desmond I J Morrow; Diarmaid J Murphy; A David Woolfson; Ryan F Donnelly
In vitro phototoxicity of 5-aminolevulinic acid and its methyl ester and the influence of barrier properties on their release from a bioadhesive patch.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2006;63(3):295-309.
2006: Ryan F Donnelly; Li-Wei Ma; Petras Juzenas; Vladimir Iani; Paul A McCarron; A David Woolfson; Johan Moan
Topical bioadhesive patch systems enhance selectivity of protoporphyrin IX accumulation.
Photochemistry and photobiology 2006;82(3):670-5.
2006: Paul A McCarron; Ryan F Donnelly; Agnieszka A Zawislak; A David Woolfson
Design and evaluation of a water-soluble bioadhesive patch formulation for cutaneous delivery of 5-aminolevulinic acid to superficial neoplastic lesions.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2006;27(2-3):268-79.
2006: Ryan F Donnelly; Paul A McCarron; Agnieszka A Zawislak; A David Woolfson
Design and physicochemical characterisation of a bioadhesive patch for dose-controlled topical delivery of imiquimod.
International journal of pharmaceutics 2006;307(2):318-25.
2006: Ryan F Donnelly; Desmond I J Morrow; Paul A McCarron; Petras Juzenas; A David Woolfson
Pharmaceutical analysis of 5-aminolevulinic acid in solution and in tissues.
Journal of photochemistry and photobiology. B, Biology 2006;82(1):59-71.
2006: Paul A McCarron; Li-Wei Ma; Petras Juzenas; Vladimir Lani; A David Woolfson; Agnieszka A Zawislak; Johan Moan
Facilitated delivery of ALA to inaccessible regions via bioadhesive patch systems.
Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer 2006;25(1-2):389-402.
2005: Paul A McCarron; Shane A Olwill; Waleed M Y Marouf; Richard J Buick; Brian Walker; Christopher J Scott
Antibody conjugates and therapeutic strategies.
Molecular interventions 2005;5(6):368-80.
2005: Paul A McCarron; Ryan F Donnelly; Gavin P Andrews; A David Woolfson
Stability of 5-aminolevulinic acid in novel non-aqueous gel and patch-type systems intended for topical application.
Journal of pharmaceutical sciences 2005;94(8):1756-71.
2005: Ryan F Donnelly; Paul A McCarron; A David Woolfson
Drug delivery of aminolevulinic acid from topical formulations intended for photodynamic therapy.
Photochemistry and photobiology 2005;81(4):750-67.
2005: Paul A McCarron; Ryan F Donnelly; Agnieszka A Zawislak; A David Woolfson; John H Price; Raymond McClelland
Evaluation of a water-soluble bioadhesive patch for photodynamic therapy of vulval lesions.
International journal of pharmaceutics 2005;293(1-2):11-23.
2005: Ryan F Donnelly; Paul A McCarron; Julie M Lightowler; A David Woolfson
Bioadhesive patch-based delivery of 5-aminolevulinic acid to the nail for photodynamic therapy of onychomycosis.
Journal of controlled release : official journal of the Controlled Release Society 2005;103(2):381-92.
2005: Paul A McCarron; Ryan F Donnelly; A David Woolfson; Gavin P Andrews
Analysis of pyrazine 2,5-dipropionic acid in 5-aminolevulinic acid-loaded urological and topical delivery vehicles: methodology and assay validation.
Journal of pharmaceutical and biomedical analysis 2005;36(5):1099-105.
2004: Paul A McCarron; Ryan F Donnelly; Brendan F Gilmore; A David Woolfson; Raymond McClelland; Agnieszka A Zawislak; John H Price
Phototoxicity of 5-aminolevulinic acid in the HeLa cell line as an indicative measure of photodynamic effect after topical administration to gynecological lesions of intraepithelial form.
Pharmaceutical research 2004;21(10):1871-9.
2004: Agnieszka A Zawislak; Paul A McCarron; W Glenn McCluggage; John H Price; Ryan F Donnelly; H Raymond McClelland; Stephen Dobbs; A David Woolfson
Successful photodynamic therapy of vulval Paget's disease using a novel patch-based delivery system containing 5-aminolevulinic acid.
BJOG : an international journal of obstetrics and gynaecology 2004;111(10):1143-5.
2004: Sharareh Ahmadi; Paul A McCarron; Ryan F Donnelly; A David Woolfson; Kevin McKenna
Evaluation of the penetration of 5-aminolevulinic acid through basal cell carcinoma: a pilot study.
Experimental dermatology 2004;13(7):445-51.
2004: Paul A McCarron; Ryan F Donnelly; Paul E Canning; James G McGovern; David S Jones
Bioadhesive, non-drug-loaded nanoparticles as modulators of candidal adherence to buccal epithelial cells: a potentially novel prophylaxis for candidosis.
Biomaterials 2004;25(12):2399-407.
2000: Paul A McCarron; A David Woolfson; S M Keating
Sustained release of 5-fluorouracil from polymeric nanoparticles.
The Journal of pharmacy and pharmacology 2000;52(12):1451-9.
1999: Paul A McCarron; A David Woolfson; S M Keating
Response surface methodology as a predictive tool for determining the effects of preparation conditions on the physicochemical properties of poly(isobutylcyanoacrylate) nanoparticles.
International journal of pharmaceutics 1999;193(1):37-47.
1997: H K Sidhu; J H Price; Paul A McCarron; D F McCafferty; A D Woolfson; D Biggart; W Thompson
A randomised controlled trial evaluating a novel cytotoxic drug delivery system for the treatment of cervical intraepithelial neoplasia.
British journal of obstetrics and gynaecology 1997;104(2):145-9.
1995: A David Woolfson; Dermot F McCafferty; Paul A McCarron; J H Price
Autoradiographic imaging of the distribution of 5-fluorouracil through cervical tissue following in vitro surface application of a bioadhesive cervical patch.
Pharmaceutical research 1995;12(5):676-81.
1994: A David Woolfson; Dermot F McCafferty; Paul A McCarron; J H Price
Liquid scintillation spectrometry of 5-fluorouracil in cervical tissue following in vitro surface application of a bioadhesive cervical patch.
Pharmaceutical research 1994;11(9):1315-9.